A detailed history of Skopos Labs, Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 136,327 shares of MRVI stock, worth $496,230. This represents 0.05% of its overall portfolio holdings.

Number of Shares
136,327
Previous 163,174 16.45%
Holding current value
$496,230
Previous $468,000 16.45%
% of portfolio
0.05%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$2.03 - $2.89 $54,499 - $77,587
-26,847 Reduced 16.45%
136,327 $391,000
Q3 2025

Nov 14, 2025

BUY
$2.03 - $2.89 $50,076 - $71,290
24,668 Added 17.81%
163,174 $468,000
Q2 2025

Aug 14, 2025

BUY
$1.72 - $2.47 $238,230 - $342,109
138,506 New
138,506 $333,000
Q3 2024

Nov 13, 2024

BUY
$6.84 - $9.73 $882 - $1,255
129 New
129 $1,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $479M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Skopos Labs, Inc. Portfolio

Follow Skopos Labs, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skopos Labs, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Skopos Labs, Inc. with notifications on news.